ENZO BIOCHEM INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2014 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Enzo Biochem Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2014 to Q1 2024.
  • Enzo Biochem Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending April 30, 2024 was 51.2K shares, a 3.71% increase year-over-year.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 49.2K shares, a 1.17% increase from 2022.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48.6K shares, a 0.84% increase from 2021.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 48.2K shares, a 1.04% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 51.2K +1.83K +3.71% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 50.5K +1.76K +3.61% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 50.2K +1.46K +3.01% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 49.2K +566 +1.17% May 1, 2023 Jul 31, 2023 10-K 2023-11-03
Q1 2023 49.4K +671 +1.38% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 48.7K +257 +0.53% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 48.7K +248 +0.51% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 48.6K +403 +0.84% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 48.7K +322 +0.67% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 48.5K +466 +0.97% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 48.5K +577 +1.21% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 48.2K +495 +1.04% May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 48.4K +611 +1.28% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 48K +449 +0.94% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 47.9K +338 +0.71% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 47.7K May 1, 2020 Jul 31, 2020 10-K 2022-10-14
Q1 2020 47.8K +328 +0.69% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 47.6K Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 47.6K Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q1 2019 47.5K -47M -99.9% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q1 2018 47.1M* +706K +1.52% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q3 2017 46.9M* +642K +1.39% Aug 1, 2017 Oct 31, 2017 10-Q 2017-12-07
Q1 2017 46.4M* +166K +0.36% Feb 1, 2017 Apr 30, 2017 10-Q 2017-06-08
Q4 2016 46.3M* +215K +0.47% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-13
Q3 2016 46.3M* +204K +0.44% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q1 2016 46.2M* +404K +0.88% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 46.1M* +1.08M +2.39% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 46.1M* +1.5M +3.38% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q1 2015 45.8M* Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 45M* Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 44.6M* Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.